Share Price and Basic Stock Data
Last Updated: February 6, 2026, 8:42 pm
| PEG Ratio | 37.04 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Expleo Solutions Ltd operates in the IT Consulting and Software industry, with its stock currently priced at ₹897 and a market capitalization of ₹1,394 Cr. The company reported sales of ₹903 Cr for the fiscal year ending March 2023, which increased to ₹965 Cr for March 2024, and is projected to reach ₹1,025 Cr for March 2025. The quarterly sales figures show a consistent upward trend, from ₹220 Cr in September 2022 to ₹234 Cr in September 2023, culminating in ₹250 Cr anticipated in December 2023. This demonstrates a robust growth trajectory, with total revenues for the trailing twelve months (TTM) standing at ₹1,056 Cr. The growth in sales reflects strong demand for Expleo’s services and a recovery in the IT sector, which has been pivotal for its expansion. Overall, the company has shown resilience and adaptability in a competitive landscape, marking an upward trend in revenue generation.
Profitability and Efficiency Metrics
Expleo Solutions reported a net profit of ₹134 Cr for the fiscal year ending March 2023, which increased to ₹90 Cr in March 2024 and is expected to rise to ₹103 Cr in March 2025. The operating profit margin (OPM) stood at 22% for March 2023 but declined to 15% for March 2024, indicating some pressure on margins amid rising costs. The company’s return on equity (ROE) is robust at 16.3%, while the return on capital employed (ROCE) is recorded at 21.5%. These figures suggest effective utilization of capital and shareholder funds. The interest coverage ratio (ICR) is exceptionally high at 54.75x, highlighting the company’s ability to meet its interest obligations comfortably. However, the declining OPM and fluctuations in profit indicate the need for careful cost management to sustain profitability in the face of potential economic headwinds.
Balance Sheet Strength and Financial Ratios
The balance sheet of Expleo Solutions demonstrates solid financial health, with total assets of ₹831 Cr as of March 2025, against total liabilities of ₹831 Cr. The company has reported reserves of ₹688 Cr, indicating a strong equity base. Borrowings stood at a modest ₹20 Cr, reflecting a conservative capital structure and low leverage. The price-to-book value (P/BV) ratio is recorded at 1.94x, suggesting that the stock is trading at a premium relative to its book value, which is a positive indicator for investors. The current ratio of 3.90x indicates strong liquidity, allowing the company to cover its short-term obligations effectively. These financial metrics position Expleo well against industry peers, highlighting its financial stability and operational efficiency.
Shareholding Pattern and Investor Confidence
As of September 2025, Expleo Solutions has a promoter holding of 71.05%, which reflects a strong commitment from the management to the company’s long-term vision. The public holds 28% of the shares, indicating a healthy distribution of ownership. Institutional investor participation remains minimal, with foreign institutional investors (FIIs) at 0.13% and domestic institutional investors (DIIs) at 0.84%. This low institutional interest could suggest potential room for growth in investor confidence, particularly as the company continues to demonstrate strong performance metrics. The increase in the number of shareholders from 21,236 in December 2022 to 29,017 in September 2025 signifies growing retail interest and confidence in Expleo’s strategic direction and operational success.
Outlook, Risks, and Final Insight
The outlook for Expleo Solutions appears promising due to its consistent revenue growth and healthy profitability metrics. However, the company faces risks related to margin compression as reflected in the declining OPM and potential economic uncertainties that could impact IT spending. Additionally, low institutional ownership may hinder stock liquidity and market perception. Strengths include a solid balance sheet, high interest coverage, and strong management commitment, which provide a cushion against market volatility. In a scenario where operational efficiencies improve and costs are managed effectively, Expleo could see enhanced profitability and investor interest. Conversely, if inflationary pressures persist and operational costs rise, profitability may erode, affecting investor sentiment negatively. Overall, Expleo Solutions is well-positioned to capitalize on growth opportunities while navigating the challenges of the IT landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Visesh Infotecnics Ltd | 125 Cr. | 0.33 | / | 1.11 | 0.00 % | 2.21 % | 2.23 % | 1.00 | |
| Mudunuru Ltd | 40.3 Cr. | 12.7 | 21.0/4.43 | 0.20 | 0.00 % | 27.0 % | 90.7 % | 2.00 | |
| Naapbooks Ltd | 128 Cr. | 119 | 194/99.8 | 19.6 | 36.4 | 0.00 % | 23.6 % | 17.1 % | 10.0 |
| IB Infotech Enterprises Ltd | 47.4 Cr. | 370 | 446/140 | 29.6 | 26.7 | 0.27 % | 38.5 % | 35.4 % | 10.0 |
| Hit Kit Global Solutions Ltd | 11.0 Cr. | 2.03 | 2.03/0.91 | 2.47 | 0.00 % | 2.14 % | 2.15 % | 2.00 | |
| Industry Average | 19,427.97 Cr | 510.93 | 79.03 | 123.52 | 0.63% | 14.88% | 20.92% | 6.84 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 240 | 231 | 225 | 234 | 250 | 255 | 252 | 259 | 258 | 256 | 260 | 283 | 279 |
| Expenses | 168 | 188 | 192 | 200 | 212 | 221 | 213 | 217 | 219 | 216 | 230 | 236 | 233 |
| Operating Profit | 72 | 43 | 33 | 34 | 38 | 34 | 39 | 42 | 39 | 40 | 30 | 47 | 46 |
| OPM % | 30% | 19% | 15% | 14% | 15% | 13% | 15% | 16% | 15% | 16% | 11% | 17% | 16% |
| Other Income | 13 | 4 | 2 | 2 | 11 | 2 | 2 | 13 | 3 | 5 | 7 | 13 | -6 |
| Interest | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Depreciation | 7 | 7 | 8 | 8 | 8 | 9 | 9 | 10 | 12 | 8 | 8 | 7 | 7 |
| Profit before tax | 77 | 39 | 26 | 27 | 41 | 26 | 31 | 44 | 28 | 36 | 28 | 51 | 32 |
| Tax % | 28% | 26% | 22% | 24% | 16% | 40% | 23% | 20% | 30% | 32% | 28% | 23% | 31% |
| Net Profit | 55 | 29 | 20 | 21 | 34 | 16 | 24 | 35 | 20 | 24 | 20 | 40 | 22 |
| EPS in Rs | 54.00 | 28.34 | 13.01 | 13.22 | 21.93 | 10.12 | 15.40 | 22.87 | 12.75 | 15.52 | 13.16 | 25.62 | 14.26 |
Last Updated: February 6, 2026, 1:16 am
Below is a detailed analysis of the quarterly data for Expleo Solutions Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 279.00 Cr.. The value appears to be declining and may need further review. It has decreased from 283.00 Cr. (Sep 2025) to 279.00 Cr., marking a decrease of 4.00 Cr..
- For Expenses, as of Dec 2025, the value is 233.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 236.00 Cr. (Sep 2025) to 233.00 Cr., marking a decrease of 3.00 Cr..
- For Operating Profit, as of Dec 2025, the value is 46.00 Cr.. The value appears to be declining and may need further review. It has decreased from 47.00 Cr. (Sep 2025) to 46.00 Cr., marking a decrease of 1.00 Cr..
- For OPM %, as of Dec 2025, the value is 16.00%. The value appears to be declining and may need further review. It has decreased from 17.00% (Sep 2025) to 16.00%, marking a decrease of 1.00%.
- For Other Income, as of Dec 2025, the value is -6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 13.00 Cr. (Sep 2025) to -6.00 Cr., marking a decrease of 19.00 Cr..
- For Interest, as of Dec 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.00 Cr. (Sep 2025) to 0.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Dec 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 7.00 Cr..
- For Profit before tax, as of Dec 2025, the value is 32.00 Cr.. The value appears to be declining and may need further review. It has decreased from 51.00 Cr. (Sep 2025) to 32.00 Cr., marking a decrease of 19.00 Cr..
- For Tax %, as of Dec 2025, the value is 31.00%. The value appears to be increasing, which may not be favorable. It has increased from 23.00% (Sep 2025) to 31.00%, marking an increase of 8.00%.
- For Net Profit, as of Dec 2025, the value is 22.00 Cr.. The value appears to be declining and may need further review. It has decreased from 40.00 Cr. (Sep 2025) to 22.00 Cr., marking a decrease of 18.00 Cr..
- For EPS in Rs, as of Dec 2025, the value is 14.26. The value appears to be declining and may need further review. It has decreased from 25.62 (Sep 2025) to 14.26, marking a decrease of 11.36.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:23 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 194 | 214 | 264 | 260 | 271 | 283 | 270 | 301 | 743 | 903 | 965 | 1,025 | 1,056 |
| Expenses | 155 | 177 | 210 | 219 | 231 | 230 | 217 | 231 | 618 | 703 | 816 | 859 | 901 |
| Operating Profit | 40 | 37 | 54 | 41 | 40 | 53 | 53 | 70 | 124 | 200 | 149 | 166 | 155 |
| OPM % | 20% | 17% | 20% | 16% | 15% | 19% | 20% | 23% | 17% | 22% | 15% | 16% | 15% |
| Other Income | 10 | 2 | 6 | 1 | 13 | 6 | 8 | 5 | 6 | 16 | 7 | 16 | 27 |
| Interest | 2 | 2 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 3 | 3 | 3 |
| Depreciation | 6 | 5 | 4 | 5 | 6 | 6 | 6 | 6 | 19 | 28 | 34 | 39 | 36 |
| Profit before tax | 42 | 32 | 56 | 37 | 48 | 54 | 54 | 68 | 110 | 186 | 120 | 139 | 144 |
| Tax % | 29% | 32% | 34% | 36% | 33% | 32% | 26% | 26% | 39% | 28% | 24% | 26% | |
| Net Profit | 30 | 22 | 37 | 24 | 32 | 36 | 40 | 50 | 68 | 134 | 90 | 103 | 104 |
| EPS in Rs | 29.26 | 20.53 | 34.68 | 22.29 | 29.86 | 33.79 | 38.92 | 49.20 | 66.01 | 130.59 | 58.27 | 66.52 | 67.05 |
| Dividend Payout % | 31% | 117% | 69% | 108% | 80% | 0% | 0% | 0% | 0% | 6% | 0% | 75% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -26.67% | 68.18% | -35.14% | 33.33% | 12.50% | 11.11% | 25.00% | 36.00% | 97.06% | -32.84% | 14.44% |
| Change in YoY Net Profit Growth (%) | 0.00% | 94.85% | -103.32% | 68.47% | -20.83% | -1.39% | 13.89% | 11.00% | 61.06% | -129.89% | 47.28% |
Expleo Solutions Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 31% |
| 3 Years: | 11% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 21% |
| 3 Years: | 14% |
| TTM: | 6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 16% |
| 3 Years: | -8% |
| 1 Year: | -22% |
| Return on Equity | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 21% |
| 3 Years: | 20% |
| Last Year: | 16% |
Last Updated: September 5, 2025, 3:50 am
Balance Sheet
Last Updated: December 4, 2025, 1:13 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 11 | 11 | 11 | 11 | 11 | 10 | 10 | 16 | 16 | 16 | 16 | 16 |
| Reserves | 98 | 91 | 98 | 116 | 118 | 128 | 142 | 192 | 379 | 515 | 596 | 620 | 688 |
| Borrowings | 12 | 10 | 0 | 0 | 0 | 0 | 0 | 7 | 15 | 26 | 26 | 30 | 20 |
| Other Liabilities | 27 | 54 | 73 | 43 | 63 | 53 | 62 | 56 | 185 | 174 | 128 | 165 | 192 |
| Total Liabilities | 147 | 165 | 182 | 171 | 191 | 192 | 214 | 264 | 594 | 730 | 765 | 831 | 916 |
| Fixed Assets | 27 | 24 | 25 | 27 | 22 | 19 | 26 | 25 | 108 | 142 | 131 | 113 | 91 |
| CWIP | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 6 | 5 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 0 | 0 |
| Other Assets | 119 | 139 | 157 | 144 | 169 | 173 | 188 | 239 | 480 | 582 | 614 | 719 | 825 |
| Total Assets | 147 | 165 | 182 | 171 | 191 | 192 | 214 | 264 | 594 | 730 | 765 | 831 | 916 |
Below is a detailed analysis of the balance sheet data for Expleo Solutions Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 16.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 16.00 Cr..
- For Reserves, as of Sep 2025, the value is 688.00 Cr.. The value appears strong and on an upward trend. It has increased from 620.00 Cr. (Mar 2025) to 688.00 Cr., marking an increase of 68.00 Cr..
- For Borrowings, as of Sep 2025, the value is 20.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 30.00 Cr. (Mar 2025) to 20.00 Cr., marking a decrease of 10.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 192.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 165.00 Cr. (Mar 2025) to 192.00 Cr., marking an increase of 27.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 916.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 831.00 Cr. (Mar 2025) to 916.00 Cr., marking an increase of 85.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 91.00 Cr.. The value appears to be declining and may need further review. It has decreased from 113.00 Cr. (Mar 2025) to 91.00 Cr., marking a decrease of 22.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 825.00 Cr.. The value appears strong and on an upward trend. It has increased from 719.00 Cr. (Mar 2025) to 825.00 Cr., marking an increase of 106.00 Cr..
- For Total Assets, as of Sep 2025, the value is 916.00 Cr.. The value appears strong and on an upward trend. It has increased from 831.00 Cr. (Mar 2025) to 916.00 Cr., marking an increase of 85.00 Cr..
Notably, the Reserves (688.00 Cr.) exceed the Borrowings (20.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 28.00 | 27.00 | 54.00 | 41.00 | 40.00 | 53.00 | 53.00 | 63.00 | 109.00 | 174.00 | 123.00 | 136.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 105 | 97 | 75 | 60 | 92 | 59 | 103 | 74 | 85 | 97 | 94 | 79 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 105 | 97 | 75 | 60 | 92 | 59 | 103 | 74 | 85 | 97 | 94 | 79 |
| Working Capital Days | 68 | 23 | -7 | 8 | 21 | 15 | 50 | 48 | 46 | 93 | 112 | 67 |
| ROCE % | 40% | 29% | 51% | 31% | 38% | 40% | 38% | 39% | 36% | 39% | 20% | 21% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Invesco India Multicap Fund | 133,972 | 0.66 | 17.73 | 133,972 | 2025-04-22 15:56:58 | 0% |
| Invesco India Smallcap Fund | 127,985 | 0.59 | 16.93 | 127,985 | 2025-04-22 15:56:58 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 66.52 | 58.27 | 86.27 | 52.58 | 49.20 |
| Diluted EPS (Rs.) | 66.52 | 58.27 | 86.27 | 52.58 | 49.20 |
| Cash EPS (Rs.) | 91.85 | 79.96 | 157.79 | 60.32 | 54.86 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 409.69 | 393.78 | 512.06 | 248.93 | 196.90 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 409.69 | 393.78 | 512.06 | 248.93 | 196.90 |
| Revenue From Operations / Share (Rs.) | 660.31 | 621.69 | 881.09 | 394.57 | 293.50 |
| PBDIT / Share (Rs.) | 117.18 | 100.42 | 210.93 | 78.85 | 73.42 |
| PBIT / Share (Rs.) | 91.86 | 78.73 | 183.73 | 71.11 | 67.75 |
| PBT / Share (Rs.) | 89.72 | 77.05 | 181.53 | 70.37 | 66.72 |
| Net Profit / Share (Rs.) | 66.52 | 58.27 | 130.60 | 52.58 | 49.20 |
| NP After MI And SOA / Share (Rs.) | 66.52 | 58.27 | 130.60 | 52.58 | 49.20 |
| PBDIT Margin (%) | 17.74 | 16.15 | 23.93 | 19.98 | 25.01 |
| PBIT Margin (%) | 13.91 | 12.66 | 20.85 | 18.02 | 23.08 |
| PBT Margin (%) | 13.58 | 12.39 | 20.60 | 17.83 | 22.73 |
| Net Profit Margin (%) | 10.07 | 9.37 | 14.82 | 13.32 | 16.76 |
| NP After MI And SOA Margin (%) | 10.07 | 9.37 | 14.82 | 13.32 | 16.76 |
| Return on Networth / Equity (%) | 16.23 | 14.79 | 25.50 | 21.12 | 24.98 |
| Return on Capital Employeed (%) | 20.76 | 18.48 | 33.48 | 27.11 | 33.16 |
| Return On Assets (%) | 12.42 | 11.82 | 18.33 | 15.65 | 19.08 |
| Asset Turnover Ratio (%) | 1.28 | 1.29 | 1.84 | 1.46 | 1.36 |
| Current Ratio (X) | 3.90 | 5.77 | 3.30 | 3.84 | 4.11 |
| Quick Ratio (X) | 3.90 | 5.77 | 3.30 | 3.84 | 4.11 |
| Dividend Payout Ratio (NP) (%) | 75.16 | 8.58 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 54.43 | 6.25 | 0.00 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 24.84 | 91.42 | 0.00 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 45.57 | 93.75 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 54.75 | 59.74 | 95.85 | 106.51 | 71.28 |
| Interest Coverage Ratio (Post Tax) (X) | 32.08 | 35.66 | 60.35 | 72.02 | 48.77 |
| Enterprise Value (Cr.) | 1006.97 | 1697.97 | 1111.70 | 1571.40 | 398.52 |
| EV / Net Operating Revenue (X) | 0.98 | 1.76 | 1.23 | 3.88 | 1.32 |
| EV / EBITDA (X) | 5.54 | 10.89 | 5.14 | 19.44 | 5.29 |
| MarketCap / Net Operating Revenue (X) | 1.21 | 1.95 | 1.40 | 4.27 | 1.76 |
| Retention Ratios (%) | 24.83 | 91.41 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 1.94 | 3.08 | 2.41 | 6.77 | 2.62 |
| Price / Net Operating Revenue (X) | 1.21 | 1.95 | 1.40 | 4.27 | 1.76 |
| EarningsYield | 0.08 | 0.04 | 0.10 | 0.03 | 0.09 |
After reviewing the key financial ratios for Expleo Solutions Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 66.52. This value is within the healthy range. It has increased from 58.27 (Mar 24) to 66.52, marking an increase of 8.25.
- For Diluted EPS (Rs.), as of Mar 25, the value is 66.52. This value is within the healthy range. It has increased from 58.27 (Mar 24) to 66.52, marking an increase of 8.25.
- For Cash EPS (Rs.), as of Mar 25, the value is 91.85. This value is within the healthy range. It has increased from 79.96 (Mar 24) to 91.85, marking an increase of 11.89.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 409.69. It has increased from 393.78 (Mar 24) to 409.69, marking an increase of 15.91.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 409.69. It has increased from 393.78 (Mar 24) to 409.69, marking an increase of 15.91.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 660.31. It has increased from 621.69 (Mar 24) to 660.31, marking an increase of 38.62.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 117.18. This value is within the healthy range. It has increased from 100.42 (Mar 24) to 117.18, marking an increase of 16.76.
- For PBIT / Share (Rs.), as of Mar 25, the value is 91.86. This value is within the healthy range. It has increased from 78.73 (Mar 24) to 91.86, marking an increase of 13.13.
- For PBT / Share (Rs.), as of Mar 25, the value is 89.72. This value is within the healthy range. It has increased from 77.05 (Mar 24) to 89.72, marking an increase of 12.67.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 66.52. This value is within the healthy range. It has increased from 58.27 (Mar 24) to 66.52, marking an increase of 8.25.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 66.52. This value is within the healthy range. It has increased from 58.27 (Mar 24) to 66.52, marking an increase of 8.25.
- For PBDIT Margin (%), as of Mar 25, the value is 17.74. This value is within the healthy range. It has increased from 16.15 (Mar 24) to 17.74, marking an increase of 1.59.
- For PBIT Margin (%), as of Mar 25, the value is 13.91. This value is within the healthy range. It has increased from 12.66 (Mar 24) to 13.91, marking an increase of 1.25.
- For PBT Margin (%), as of Mar 25, the value is 13.58. This value is within the healthy range. It has increased from 12.39 (Mar 24) to 13.58, marking an increase of 1.19.
- For Net Profit Margin (%), as of Mar 25, the value is 10.07. This value exceeds the healthy maximum of 10. It has increased from 9.37 (Mar 24) to 10.07, marking an increase of 0.70.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 10.07. This value is within the healthy range. It has increased from 9.37 (Mar 24) to 10.07, marking an increase of 0.70.
- For Return on Networth / Equity (%), as of Mar 25, the value is 16.23. This value is within the healthy range. It has increased from 14.79 (Mar 24) to 16.23, marking an increase of 1.44.
- For Return on Capital Employeed (%), as of Mar 25, the value is 20.76. This value is within the healthy range. It has increased from 18.48 (Mar 24) to 20.76, marking an increase of 2.28.
- For Return On Assets (%), as of Mar 25, the value is 12.42. This value is within the healthy range. It has increased from 11.82 (Mar 24) to 12.42, marking an increase of 0.60.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.28. It has decreased from 1.29 (Mar 24) to 1.28, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 3.90. This value exceeds the healthy maximum of 3. It has decreased from 5.77 (Mar 24) to 3.90, marking a decrease of 1.87.
- For Quick Ratio (X), as of Mar 25, the value is 3.90. This value exceeds the healthy maximum of 2. It has decreased from 5.77 (Mar 24) to 3.90, marking a decrease of 1.87.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 75.16. This value exceeds the healthy maximum of 50. It has increased from 8.58 (Mar 24) to 75.16, marking an increase of 66.58.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 54.43. This value exceeds the healthy maximum of 50. It has increased from 6.25 (Mar 24) to 54.43, marking an increase of 48.18.
- For Earning Retention Ratio (%), as of Mar 25, the value is 24.84. This value is below the healthy minimum of 40. It has decreased from 91.42 (Mar 24) to 24.84, marking a decrease of 66.58.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 45.57. This value is within the healthy range. It has decreased from 93.75 (Mar 24) to 45.57, marking a decrease of 48.18.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 54.75. This value is within the healthy range. It has decreased from 59.74 (Mar 24) to 54.75, marking a decrease of 4.99.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 32.08. This value is within the healthy range. It has decreased from 35.66 (Mar 24) to 32.08, marking a decrease of 3.58.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,006.97. It has decreased from 1,697.97 (Mar 24) to 1,006.97, marking a decrease of 691.00.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1. It has decreased from 1.76 (Mar 24) to 0.98, marking a decrease of 0.78.
- For EV / EBITDA (X), as of Mar 25, the value is 5.54. This value is within the healthy range. It has decreased from 10.89 (Mar 24) to 5.54, marking a decrease of 5.35.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has decreased from 1.95 (Mar 24) to 1.21, marking a decrease of 0.74.
- For Retention Ratios (%), as of Mar 25, the value is 24.83. This value is below the healthy minimum of 30. It has decreased from 91.41 (Mar 24) to 24.83, marking a decrease of 66.58.
- For Price / BV (X), as of Mar 25, the value is 1.94. This value is within the healthy range. It has decreased from 3.08 (Mar 24) to 1.94, marking a decrease of 1.14.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has decreased from 1.95 (Mar 24) to 1.21, marking a decrease of 0.74.
- For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.08, marking an increase of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Expleo Solutions Ltd:
- Net Profit Margin: 10.07%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 20.76% (Industry Average ROCE: 14.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 16.23% (Industry Average ROE: 20.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 32.08
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.9
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 11.6 (Industry average Stock P/E: 79.03)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.07%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | 6A, Sixth Floor, Prince Infocity II, Chennai (Madras) Tamil Nadu 600096 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ralph Franz Gillessen | Chairman & Non-Exe.Director |
| Mr. Phani Tangirala | Managing Director & CEO |
| Mr. Rajesh Krishnamurthy | Non Executive Director |
| Mr. Narayanan Subramaniam | Independent Director |
| Dr. Srivardhini Keshavamurthy Jha | Independent Director |
| Dr. Varadharajan Sridhar | Independent Director |
| Ms. Shalini Kalsi Kamath | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Expleo Solutions Ltd?
Expleo Solutions Ltd's intrinsic value (as of 07 February 2026) is ₹726.69 which is 16.85% lower the current market price of ₹874.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,354 Cr. market cap, FY2025-2026 high/low of ₹1,371/686, reserves of ₹688 Cr, and liabilities of ₹916 Cr.
What is the Market Cap of Expleo Solutions Ltd?
The Market Cap of Expleo Solutions Ltd is 1,354 Cr..
What is the current Stock Price of Expleo Solutions Ltd as on 07 February 2026?
The current stock price of Expleo Solutions Ltd as on 07 February 2026 is ₹874.
What is the High / Low of Expleo Solutions Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Expleo Solutions Ltd stocks is ₹1,371/686.
What is the Stock P/E of Expleo Solutions Ltd?
The Stock P/E of Expleo Solutions Ltd is 11.6.
What is the Book Value of Expleo Solutions Ltd?
The Book Value of Expleo Solutions Ltd is 453.
What is the Dividend Yield of Expleo Solutions Ltd?
The Dividend Yield of Expleo Solutions Ltd is 5.72 %.
What is the ROCE of Expleo Solutions Ltd?
The ROCE of Expleo Solutions Ltd is 21.5 %.
What is the ROE of Expleo Solutions Ltd?
The ROE of Expleo Solutions Ltd is 16.3 %.
What is the Face Value of Expleo Solutions Ltd?
The Face Value of Expleo Solutions Ltd is 10.0.